Navigate regulatory challenges and reach HCPs on social media in the ongoing COVID times
According to a recent survey, 72% of physicians are active on Facebook in general, and 38% are active on Instagram and LinkedIn weekly.
With access to HCPs limited due to COVID-19, the Pharmaceutical and Life Science industry have an urgent need to find ways to continue engaging with these important stakeholders on a regular basis.
Since Pharmaceutical and Life Science sales representatives no longer have in-person access to many HCPs, leaders in this space need a compliant path forward to leveraging the social media networks of these critical employees to reach and connect with HCPs in new ways, while maintaining compliance within a highly regulated environment.
Our recent session focused exactly on this new age social challenge for Pharmaceutical and Life Science brands.
– Learn about a proven, regulated social media approach to leveraging the social networks of sales reps to reach HCPs
– Eliminate risk and human errors by tightly integrating social media publishing with internal processes to ensure your team is only publishing approved content
– Reduce social media content time to market
– Get a sneak-peek into MarketBeam – a regulation-driven social media publishing, amplifying, and monitoring platform that is seamlessly integrated with Veeva Vault PromoMats
Growth-Focused Amplification for US Financial Services
Explore how to be compliant with FINRA and SEC.
Social Media Amplification for Pharma
Distribute Compliant Social Media Content Directly from Veeva Vault.
Pharma Social Media Marketing
Explore how to Expedite Time to Market in 2021